A Pilot Study of Tumor-Derived Exosomes as Diagnostic and Prognostic Markers in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
This study is currently recruiting participants.
Verified January 2012 by Leo W. Jenkins Cancer Center
Sponsor:
Leo W. Jenkins Cancer Center
Information provided by (Responsible Party):
Jackie Unger, Leo W. Jenkins Cancer Center
ClinicalTrials.gov Identifier:
NCT01344109
First received: April 27, 2011
Last updated: January 3, 2013
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | December 2014 (Final data collection date for primary outcome measure) |